Connection

Alfred Kim to Humans

Back to Details
This is a "connection" page, showing publications Alfred Kim has written about Humans.
Alfred Kim
Connection Strength
0.071
Humans
  1. Inflammatory arthritis in patients with COVID-19. Transl Res. 2021 06; 232:49-59.
    View in: PubMed
    Score: 0.007
  2. Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease. Best Pract Res Clin Rheumatol. 2021 03; 35(1):101664.
    View in: PubMed
    Score: 0.007
  3. The interplay between neutrophils, complement, and microthrombi in COVID-19. Best Pract Res Clin Rheumatol. 2021 03; 35(1):101661.
    View in: PubMed
    Score: 0.007
  4. Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'. Expert Rev Clin Immunol. 2021 01; 17(1):105-107.
    View in: PubMed
    Score: 0.007
  5. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Ann Intern Med. 2020 06 02; 172(11):754-755.
    View in: PubMed
    Score: 0.007
  6. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16; 172(12):819-821.
    View in: PubMed
    Score: 0.007
  7. B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement. JCI Insight. 2017 11 02; 2(21).
    View in: PubMed
    Score: 0.006
  8. From mechanism to therapies in systemic lupus erythematosus. Curr Opin Rheumatol. 2017 03; 29(2):178-186.
    View in: PubMed
    Score: 0.006
  9. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
    View in: PubMed
    Score: 0.002
  10. Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain? Best Pract Res Clin Rheumatol. 2021 03; 35(1):101658.
    View in: PubMed
    Score: 0.002
  11. Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation. Expert Rev Clin Immunol. 2020 12; 16(12):1185-1204.
    View in: PubMed
    Score: 0.002
  12. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2021 01; 73(1):36-47.
    View in: PubMed
    Score: 0.002
  13. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666.
    View in: PubMed
    Score: 0.002
  14. The complement system in COVID-19: friend and foe? JCI Insight. 2020 08 06; 5(15).
    View in: PubMed
    Score: 0.002
  15. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Ann Rheum Dis. 2020 10; 79(10):1386-1388.
    View in: PubMed
    Score: 0.002
  16. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736.
    View in: PubMed
    Score: 0.002
  17. Barriers and Facilitators of Mentoring for Trainees and Early Career Investigators in Rheumatology Research: Current State, Identification of Needs, and Road Map to an Inter-Institutional Adult Rheumatology Mentoring Program. Arthritis Care Res (Hoboken). 2018 03; 70(3):445-453.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.